loader
Please Wait
Applying Filters...

Athena Athena

X

Approved Drug Products containing 202239 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AUROBINDO PHARMA LTD (6)

filter

01 CAPSULE;ORAL (6)

filter

01 RX (6)

filter

01 AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (6)

filter

01 No (6)

URL Supplier Web Content
CAPSULE; ORAL
EQ 5MG BASE;40MG
2012-09-05
202239
AMLODIPINE BESYLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 5MG BASE;10MG
2012-09-05
202239
AMLODIPINE BESYLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 10MG BASE;20MG
2012-09-05
202239
AMLODIPINE BESYLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 5MG BASE;20MG
2012-09-05
202239
AMLODIPINE BESYLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 2.5MG BASE;10MG
2012-09-05
202239
AMLODIPINE BESYLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 10MG BASE;40MG
2012-09-05
202239
AMLODIPINE BESYLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 202239

Looking for FDA Orange Book APPLICATION 202239 6

19

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE, with a corresponding application number 202239.

Regulatory Information RX

With a dosage strength EQ 5MG BASE;40MG

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2012-09-05

Therapeutic Equivalence (TE) Code AB

18

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE, with a corresponding application number 202239.

Regulatory Information RX

With a dosage strength EQ 5MG BASE;10MG

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2012-09-05

Therapeutic Equivalence (TE) Code AB

17

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE, with a corresponding application number 202239.

Regulatory Information RX

With a dosage strength EQ 10MG BASE;20MG

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2012-09-05

Therapeutic Equivalence (TE) Code AB

16

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE, with a corresponding application number 202239.

Regulatory Information RX

With a dosage strength EQ 5MG BASE;20MG

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2012-09-05

Therapeutic Equivalence (TE) Code AB

15

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE, with a corresponding application number 202239.

Regulatory Information RX

With a dosage strength EQ 2.5MG BASE;10MG

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2012-09-05

Therapeutic Equivalence (TE) Code AB

14

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE, with a corresponding application number 202239.

Regulatory Information RX

With a dosage strength EQ 10MG BASE;40MG

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2012-09-05

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY